Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio
Lupin expands its diabetes portfolio with the acquisition of GIBTULIO, GIBTULIO MET, and AJADUO trademarks
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
anti-diabetes
Cipla strengthens its anti-diabetes portfolio through partnerships with MNCs: GlobalData
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01…